Register

Downloads / CME Credit

Course Director & Faculty

Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, FECMM
Course Director and Presenter
Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, FECMM
The University of Texas
MD Anderson Cancer Center
Baylor College of Medicine
University of Houston
Houston, Texas
Michael Boeckh MD, PhD
Co-Presenter
Michael Boeckh, MD, PhD
Fred Hutchinson Cancer Research Center
University of Washington
Seattle, Washington

Location

Gaylord Palms Convention Center
Meeting Room: Florida Hall E
6000 W Osceola Pkwy
Kissimmee, FL 34746

Agenda

12:00 - 12:30 PM: Registration and Lunch

12:30 - 12:35 PM: Introduction and Key Questions on the Modern Prevention and Treatment of CMV and Invasive Fungal Infection in the HCT Setting - Dr. Kontoyiannis

12:35 - 1:00 PM: Advances in Treatment and Prevention of CMV Disease in HCT Recipients - Dr. Boeckh

1:00 - 1:25 PM: Invasive Fungal Infections in HCT Recipients: Evidence-Based Perspectives on Prevention and Treatment - Dr. Kontoyiannis

1:25 - 1:30 PM: Q&A and Concluding Remarks

CME Information

Activity Description & Educational Objectives

Hematopoietic cell transplant (HCT) recipients, especially those who have received allogeneic transplants, are at substantial risk for a variety of infections associated with high morbidity and mortality. The risk of these infections (eg, cytomegalovirus, invasive fungal infection) depends on the recipient’s degree of immunosuppression and exposure to pathogens, as well as the time elapsed since transplantation.

Join us for a live lunch symposium that will examine evidence-based strategies to minimize the burden of infections in HCT recipients. Our faculty experts will provide insight on the evolving approach to prevention and management of cytomegalovirus and invasive fungal infection, with a focus on the clinical potential of new and emerging therapeutic strategies.

Upon completion of this activity, participants should be better able to:

Target Audience

This activity has been designed to meet the educational needs of hematologists, hematologist-oncologists, advanced practice hematology/oncology nurses, bone marrow transplant clinical nurse specialists, pharmacists, transplant specialists, and other clinicians who manage patients who have undergone hematopoietic stem cell transplant.

Requirements for Successful Completion

In order to receive credit, participants must attend the live activity and complete the request for credit. There are no prerequisites and there is no fee to participate in this activity or to receive CME credit. Statements of Credit are awarded upon completion of the request for credit at the end of the post-test and evaluation form.

Media: Symposium
Release and Expiration Date: February 22, 2017
Time to Complete: 60 minutes

Faculty & Disclosure / Conflict of Interest Policy

In accordance with ACCME requirements, The Medical College of Wisconsin has a conflict of interest policy that requires faculty to disclose relevant financial relationships related to the content of their presentations/materials. Any potential conflicts are resolved so that presentations are evidence-based and scientifically balanced.

Course Director and Presenter

Dimitrios P. Kontoyiannis, MD, ScD, FACP, FIDSA, FECMM
Frances King Black Endowed Professor, Infectious Diseases
Deputy Head, Division of Internal Medicine
The University of Texas MD Anderson Cancer Center
Adjunct Professor Baylor College of Medicine
Adjunct Professor University of Houston
Houston, Texas

Co-Presenter

Michael Boeckh, MD
Member, Vaccine and Infectious Disease Division
Head, Infectious Disease Sciences Program
Fred Hutchinson Cancer Research Center
Professor, Department of Medicine, University of Washington
Seattle, Washington

Medical Director

Kathryn B. Charalambous, PhD
PVI, PeerView Institute for Medical Education

The Medical College of Wisconsin (MCW) requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by MCW for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

Providership, Credit & Support

This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of The Medical College of Wisconsin and PVI, PeerView Institute for Medical Education. The Medical College of Wisconsin is accredited by the ACCME to provide continuing medical education for physicians.

The Medical College of Wisconsin designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Providership

This CME activity is jointly provided by The Medical College of Wisconsin and PVI, PeerView Institute for Medical Education.

Support

This activity is supported by independent medical educational grants from Astellas, Merck & Co., Inc., and Shire.

Disclosure of Unlabeled Use

The faculty of this educational activity may include discussions of products or devices that are not currently labeled for use by the FDA. Faculty members have been advised to disclose to the audience any reference to an unlabeled or investigational use.

No endorsement of unapproved products or uses is made or implied by coverage of these products or uses in our reports. No responsibility is taken for errors or omissions in reports.

Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings.

Please visit our other symposia on HL, www.peerviewpress.com/HL17, AML www.peerviewpress.com/AMLBMT, Myelofibrosis, www.peerviewpress.com/MFBMT, and on Myeloma www.peerviewpress.com/MMBMT.